16 Dec 2014
A randomised control study found that, while anti-TGF-beta 1 therapy was safe and well-tolerated, it failed to slow disease progression in patients with advanced diabetic nephropathy. Clinical Endocrinology News
Call for nominations for Awards Committee Chair
30 Oct 2024
James M Tanner Award - 2025 nominations open
30 Oct 2024
Would you like to host the BSPED annual meeting?
21 Oct 2024